• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Focus areas
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Focus areas
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesFocus areasTry Devex Pro
    • News
    • COVID-19

    Boost high-risk groups before first COVID doses for low risk, says WHO

    When a country has reached moderate to high levels of COVID-19 vaccinations among high-risk groups, the next step is giving them booster shots rather than providing low-risk groups with first doses.

    By Sara Jerving // 21 January 2022
    Older people wait in line to take COVID-19 vaccine booster shots in the East Singhbhum district of Jharkhand, India. Photo by: Rohit Shaw / Pacific Press / Sipa USA via Reuters Connect

    Countries that have achieved moderate to high levels of COVID-19 vaccinations among high-risk groups — including older people and health workers — should next prioritize giving these people booster shots rather than offering first doses to low-priority groups, said the World Health Organization.

    This will “usually yield greater reductions in severe disease and death than use of equivalent vaccine supply to increase the primary vaccination series coverage rates of lower risk priority use groups,” said Alejandro Cravioto, chair of WHO’s strategic advisory group of experts on immunization, or SAGE, during a press conference on Friday.  

    Road map for boosters: This new guidance comes out of an extraordinary meeting of SAGE held on Wednesday. With these changes, WHO’s vaccine road map now includes booster shots as part of the strategy to achieve the best impact of available vaccines, said Kate O’Brien, director of WHO’s department of immunization, vaccines, and biologicals.

    “This does not mean giving boosters, as a priority, to everybody in all ages, and all priority groups. We continue to have the highest focus on the full vaccination of the highest priority groups,” she said.

    But WHO has not defined the threshold of when a country has achieved “moderate-to-high primary series coverage” of vaccinations for high-risk groups “because they may differ from country to country,” said Joachim Hombach, executive secretary of SAGE.

    Positive outlook: WHO’s analysis of the supply of COVID-19 vaccines this year shows adequate global production, said O’Brien, but the harder task is to ensure the vaccines end up in the places they are needed most.

    “There is likely to be sufficient supply, should that supply be distributed in an equitable way,” she said, adding that 34 countries are still below 10% of populations vaccinated.

    More reading:

    ► WHO calls for moratorium on booster shots

    ► 'We right now are basically out of money' for COVAX, says Gavi

    ► Prospects for local manufacturing of COVID-19 vaccines in Africa

    • Global Health
    • Trade & Policy
    • WHO
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Sara Jerving

      Sara Jervingsarajerving

      Sara Jerving is a Senior Reporter at Devex, where she covers global health. Her work has appeared in The New York Times, the Los Angeles Times, The Wall Street Journal, VICE News, and Bloomberg News among others. Sara holds a master's degree from Columbia University Graduate School of Journalism where she was a Lorana Sullivan fellow. She was a finalist for One World Media's Digital Media Award in 2021; a finalist for the Livingston Award for Young Journalists in 2018; and she was part of a VICE News Tonight on HBO team that received an Emmy nomination in 2018. She received the Philip Greer Memorial Award from Columbia University Graduate School of Journalism in 2014.

    Search for articles

    Most Read

    • 1
      Innovation meets impact: Fighting malaria in a warming world
    • 2
      The silent, growing CKD epidemic signals action is needed today
    • 3
      Building hope to bridge the surgical access gap
    • 4
      Why capital without knowledge-sharing won't solve the NCD crisis
    • 5
      3 ways AI can support drug innovation and global research equity
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2026 Devex|User Agreement|Privacy Statement